Details of the Drug Combinations

General Information of This Drug (ID: DMLUDO8)

Drug Name

Isosulfan blue DMLUDO8

Synonyms

ISOSULFAN BLUE; Sulphan Blue; Sulfanblau; Disulphin Blau; Patentblau V; Patent blau V; 68238-36-8; Isosulfan blue [USAN]; Iso-sulfan blue; UNII-39N9K8S2A4; Sulphan blue 2,5-disulfophenyl isomer; LYMPHAZURIN; P 4125; P 1888; 39N9K8S2A4; Isosulfan blue (USAN); (4-(alpha-(p-(Diethylamino)phenyl)-2,5-disulfobenzylidene)-2,5-cyclohexadien-1-ylidene)diethylammonium hydroxide, inner salt, sodium salt; P-4125; Ethanaminium, N-(4-((4-(diethylamino)phenyl)(2,5-disulfophenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, hydroxide,

Indication

Disease Entry	ICD 11	Status	REF
Investigative surgical procedure	QB8Z	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Indocyanine green + Isosulfan blue	DC8IOOF	Indocyanine green	Recurrent Melanoma	[2]
Indocyanine green + Isosulfan blue	DCCY3JR	Indocyanine green	Endometrial Cancer	[3]
------------------------------------------------------------------------------------

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2	ClinicalTrials.gov (NCT01898403) Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma
3	ClinicalTrials.gov (NCT01818739) Lymph Node Mapping in Patients With Endometrial Cancer